ArticleHealth science reports2025
Cervical, Breast, and Colorectal Cancer Screening Rates Among Sexual and Gender Minority Women in Japan: Using a Nationwide Online Survey.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Owing to the high mortality rates associated with cervical and breast cancers, increasing screening uptake is a priority. However, the current policy lacks consideration for sexual and gender minorities (SGMs). This study aimed to examine whether SGM women have lower take-up rates of these female-organ-specific cancers than non-SGM women by investigating the difference in screening frequency between them. Additionally, colorectal cancer screening was used as another outcome to determine whether the results were unique to female-organ-specific cancers. Methods: This cross-sectional study was conducted using a nationwide online survey in 2023. Information from women aged 20-69 years was used, with a sample size of 12,305, including 1371 SGM and 10,934 non-SGM individuals. As an outcome variable, the careening take-up of cervical and breast cancers was used, sex-specific cancer and being screened in Obstetrics and Gynecology, colorectal cancer, which is non-sex specific, and the screening is conducted at home. Results: Considering demographic characteristics and socioeconomic status as constants, a lower likelihood of screening for cervical and breast cancer was observed in SGM women than in non-SGM women (odds ratio [OR] 0.78; 95% confidence interval [CI] 0.69-0.88 for cervical cancer, and OR 0.77; 95% CI 0.64-0.93 for breast cancer). No difference was found between SGM and non-SGM women in colorectal cancer screening (OR 0.96; 95% CI 0.80-1.16). Conclusion: This study highlights the sexual orientation and gender identity gap in the frequency of cervical and breast cancer screenings but not in colorectal cancer screenings. This study highlights the potential barriers faced by SGM women, emphasizing the importance of raising awareness of the unique healthcare challenges, particularly concerning female-organ-specific cancers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.